Company Filing History:
2 out of 1,217 
1 out of 13 Years Active: 1997-1999
Title: Joost Oppenheim: Innovator in Immunology
Introduction
Joost Oppenheim is a prominent inventor based in Bethesda, MD (US). He has made significant contributions to the field of immunology, particularly in the development of treatments for inflammation. With a total of 3 patents, Oppenheim's work has had a lasting impact on medical research and therapeutic applications.
Latest Patents
Oppenheim's latest patents include innovative methods for treating inflammation using antibodies to neutrophils. One of his notable inventions is a method that involves an isolated, synthetic preparation of a novel neutrophil-specific chemotactic factor (NCF). This patent also discloses monoclonal antibodies that have a specific binding affinity for NCF, along with a clone containing the complete cDNA coding sequence for NCF. Another significant patent focuses on antibodies specific for the neutrophil chemotactic factor, further emphasizing the importance of NCF in therapeutic applications.
Career Highlights
Throughout his career, Oppenheim has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the United States of America as represented by the Secretary, Department. His work has been instrumental in advancing the understanding of immune responses and developing new treatment modalities.
Collaborations
Oppenheim has collaborated with notable scientists in his field, including Kouji Matsushima and Teizo Yoshimura. These collaborations have contributed to the advancement of research in immunology and the development of innovative therapies.
Conclusion
Joost Oppenheim's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of treatments for inflammation and related conditions.